NIH funds new nanomedicine center

As part of a new National Institutes of Health nanomedicine grant, David Roth, M.D., Ph.D., chairman of the department of pathology, is collaborating with colleagues at academic research institutions around the country to set up a Nanomedicine Center for Nucleoprotein Machines. Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.